Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
967,145
-
Share change
-
-11,186
-
Total reported value
-
$12,887,000
-
Price per share
-
$13.33
-
Number of holders
-
10
-
Value change
-
-$149,755
-
Number of buys
-
2
-
Number of sells
-
2
Institutional Holders of REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) as of Q4 2014
As of 31 Dec 2014,
REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
967,145 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Broadfin Capital, LLC, Candriam Luxembourg S.C.A., GOLDMAN SACHS GROUP INC, MONETARY MANAGEMENT GROUP INC, WELLS FARGO & COMPANY/MN, Tower Research Capital LLC (TRC), BANK OF AMERICA CORP /DE/, UBS Group AG, and MORGAN STANLEY.
This page lists
10
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.